These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 30010839)
81. [Risk factors for anemia in the early stages of chronic kidney disease]. Milovanov YS; Kozlovskaya LV; Milovanova LY; Markina MM; Kozlov VV; Taranova MV; Fomin VV Ter Arkh; 2017; 89(6):41-47. PubMed ID: 28745688 [TBL] [Abstract][Full Text] [Related]
82. Association between FGF23, α-Klotho, and Cardiac Abnormalities among Patients with Various Chronic Kidney Disease Stages. Tanaka S; Fujita S; Kizawa S; Morita H; Ishizaka N PLoS One; 2016; 11(7):e0156860. PubMed ID: 27400031 [TBL] [Abstract][Full Text] [Related]
83. Klotho preservation via histone deacetylase inhibition attenuates chronic kidney disease-associated bone injury in mice. Lin W; Li Y; Chen F; Yin S; Liu Z; Cao W Sci Rep; 2017 Apr; 7():46195. PubMed ID: 28387374 [TBL] [Abstract][Full Text] [Related]
84. Evaluation of a genetic risk score based on creatinine-estimated glomerular filtration rate and its association with kidney outcomes. Thio CHL; van der Most PJ; Nolte IM; van der Harst P; Bültmann U; Gansevoort RT; Snieder H Nephrol Dial Transplant; 2018 Oct; 33(10):1757-1764. PubMed ID: 29294079 [TBL] [Abstract][Full Text] [Related]
86. A Yokoyama S; Oguro R; Yamamoto K; Akasaka H; Ito N; Kawai T; Kusunoki H; Takeya Y; Takeya-Onishi M; Yamamoto-Hanasaki H; Sugimoto K; Ikebe K; Gondo Y; Ohishi M; Kamide K; Rakugi H Aging (Albany NY); 2018 Dec; 11(1):104-114. PubMed ID: 30595559 [No Abstract] [Full Text] [Related]
87. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease. Chinnadurai R; Ritchie J; Green D; Kalra PA Nephrol Dial Transplant; 2019 Mar; 34(3):449-457. PubMed ID: 29390103 [TBL] [Abstract][Full Text] [Related]
88. The optimal cut-off values of Klotho for predicting all-cause and cardiovascular mortality among chronic kidney disease: results from NHANES. Liu L; Jia J; Cheng X; Gao S; Yan T Sci Rep; 2024 Feb; 14(1):4647. PubMed ID: 38409304 [TBL] [Abstract][Full Text] [Related]
89. The rs1126616 Single Nucleotide Polymorphism of the Osteopontin Gene Is Independently Associated with Cardiovascular Events in a Chronic Kidney Disease Cohort. Cambray S; Galimudi RK; Bozic M; Bermúdez-López M; Rodríguez I; Valdivielso JM J Clin Med; 2019 Apr; 8(5):. PubMed ID: 31036794 [TBL] [Abstract][Full Text] [Related]
91. Association of Candidate Gene Polymorphisms With Chronic Kidney Disease: Results of a Case-Control Analysis in the Nefrona Cohort. Valls J; Cambray S; Pérez-Guallar C; Bozic M; Bermúdez-López M; Fernández E; Betriu À; Rodríguez I; Valdivielso JM Front Genet; 2019; 10():118. PubMed ID: 30863424 [TBL] [Abstract][Full Text] [Related]
92. Influence of Klotho gene polymorphisms on vascular gene expression and its relationship to cardiovascular disease. Donate-Correa J; Martín-Núñez E; Martínez-Sanz R; Muros-de-Fuentes M; Mora-Fernández C; Pérez-Delgado N; Navarro-González JF J Cell Mol Med; 2016 Jan; 20(1):128-33. PubMed ID: 26538295 [TBL] [Abstract][Full Text] [Related]
93. The association between Single Nucleotide Polymorphisms of Klotho Gene and Mortality in Elderly Men: The MrOS Sweden Study. Wu PH; Westerberg PA; Kindmark A; Tivesten Å; Karlsson MK; Mellström D; Ohlsson C; Fellström B; Linde T; Ljunggren Ö Sci Rep; 2020 Jun; 10(1):10243. PubMed ID: 32581247 [TBL] [Abstract][Full Text] [Related]
94. Stem cell genes in atheromatosis: The role of Klotho, HIF1α, OCT4, and BMP4. Mylonas KS; Karangelis D; Androutsopoulou V; Chalikias G; Tziakas D; Mikroulis D; Iliopoulos DC; Nikiteas N; Schizas D IUBMB Life; 2022 Oct; 74(10):1003-1011. PubMed ID: 36120844 [TBL] [Abstract][Full Text] [Related]
95. Role of deleterious nsSNPs of klotho protein and their drug response: a computational mechanical insights. Jayaraj JM; Muthusamy K J Biomol Struct Dyn; 2024 Apr; 42(6):2886-2896. PubMed ID: 37216366 [TBL] [Abstract][Full Text] [Related]
96. Association of Mendoza-Carrera F; Farías-Basulto A; Gómez-García EF; Rizo de la Torre LDC; Cueto-Manzano AM; Cortés-Sanabria L; Pérez-Coria M; Vázquez-Rivera GE J Diabetes Metab Disord; 2024 Jun; 23(1):1125-1131. PubMed ID: 38932797 [TBL] [Abstract][Full Text] [Related]
97. Systemic atheromatosis influence on retinal vascular disease. Ştefănescu A; Sas T; Bătăiosu C Curr Health Sci J; 2014; 40(3):220-4. PubMed ID: 25729610 [TBL] [Abstract][Full Text] [Related]
98. [Hypercholesterolemia, atheromatosis and the effect of decolesterinizing substances]. HERRMANN GR Cuore Circ; 1947; 31(3-4):47. PubMed ID: 20340668 [No Abstract] [Full Text] [Related]
99. Cardiovascular lifetime risk in patients with low risk in the short term. Association with carotid atheromatosis. Masson W; Huerín M; Lobo M; Siniawski D Rev Clin Esp (Barc); 2015 Oct; 215(7):417-8. PubMed ID: 25858774 [No Abstract] [Full Text] [Related]
100. Experimental Studies in Cardiovascular Pathology: XI. Thesaurosis and Atheromatosis Produced in Dogs by the Repeated Intravenous Injection of Solutions of Sodium Cellulose Glycollate. Hueper WC Am J Pathol; 1945 Sep; 21(5):1021-9. PubMed ID: 19970838 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]